pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Unicycive eyes June FDA verdict for hyperphosphataemia drug
1 day ago · FDA starts review of Unicycive's drug for hyperphosphataemia in patients with chronic kidney disease on dialysis, aiming to improve on onerous phosphate binder therapy.
The evolving role of AI in drug submission and approval: An expert ...
1 day ago · The evolving role of AI in drug submission and approval: An expert perspective. Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and ...
News | Timely industry updates for pharma and biotech leaders
The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets, pharmaphorum’s news coverage ...
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
6 days ago · Read Deep Dive: Patients & Partnerships in full pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for ...
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Building a strong pharma brand - pharmaphorum
A major priority should be to focus on customers’ satisfaction with their initial experience of the brand, with ‘customer’ – as so often in pharma – potentially be a payer, prescriber, associated healthcare provider, patient or caregiver. This is when companies need to capture and listen to real-time feedback and this needs to go ...
Deep-Dive | pharmaphorum
3 days ago · By inverting the leadership pyramid and putting patients first, we can chart a course toward a healthier, more equitable future, regardless of the political landscape. For all this, and much more ...
Pills and polls: What the 2024 election means for pharma
Oct 31, 2024 · At a memorable session at BIO this year, noted pollster Neil Newhouse shared that only 18% of Americans say they approve of the pharmaceutical industry, and 83% believe the number one factor ...
The Ozempic dilemma: Balancing demand, supply, and patient …
6 days ago · The sudden and overwhelming demand for GLP-1 agonists, like Ozempic and Wegovy, has placed immense pressure on pharmaceutical supply chains. What started as a treatment for type 2 diabetes has ...